VaramirStart free · no cardSign in
NUVB as of Nov 1 · 03:00 ET
NUVBNYSEPharmaceutical Preparations

Nuvation Bio Inc. · Brief

Next report

3 days

Nov 4 · after closeconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±27.8%
avg realized
±9.4%
Mar 6 '25±57.6%▲+6.88%×0.12
May 7 '25±58.4%▲+2.94%×0.05
Aug 7 '25±17.0%▼−0.43%×0.03
Nov 3 '25±20.2%▼−6.58%×0.33
Jan 12 '26±11.0%▼−19.65%×1.78
Q1 FY26±23.9%▼−25.34%×1.06
May 4 '26±14.9%▲+9.52%×0.64
Q2 FY26±19.6%▼−4.08%×0.21
quarterimplied−60%0+60%realized×
Q2 FY26±19.6%▼−4.08%×0.21
May '26±14.9%▲+9.52%×0.64
Q1 FY26±23.9%▼−25.34%×1.06
Jan '26±11.0%▼−19.65%×1.78
Nov '25±20.2%▼−6.58%×0.33
Aug '25±17.0%▼−0.43%×0.03
2 older reports
May '25±58.4%▲+2.94%×0.05
Mar '25±57.6%▲+6.88%×0.12
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · confirmed

Bull2

4disclosed supplier and customer tiesSEC filings
242managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

3tracked funds holding NUVBN-PORT · Aug 31 '26
5 of 23largest reporting managers reduced their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

NUVB report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21report dateEarnings date confirmed: Nov 4, after close.Source
Oct 21impliedImplied move: ±12.9% into Nov 4 earnings (Oct 21 close).Source
Oct 19impliedImplied move: ±17.6% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.